Georgia Cannabis Market

Georgia Cannabis Market Update

As of 2025, Georgia's cannabis market is experiencing significant changes, particularly within the medical cannabis program and the regulation of hemp-derived products. Lawmakers are considering new legislation that could reshape access and availability for patients and businesses.

A proposed bill aims to expand the state's medical cannabis program by introducing several key changes:

• Higher THC Limits – The allowable THC content in medical cannabis products would increase significantly, allowing for stronger formulations.
• More Consumption Options – Inhalation methods, except for raw cannabis flower, may become legal for medical use.
• Expanded Patient Eligibility – The bill seeks to broaden the list of qualifying conditions, making medical cannabis more accessible to a wider range of patients.

The legislation has passed in the state Senate and is currently under review in the House. If approved, these changes could substantially impact Georgia's medical cannabis industry.

Lawmakers are also moving to regulate hemp-derived products, particularly those containing THC variants such as delta-8 and delta-9. Recent proposals include:

• Banning THC-Infused Beverages – Concerns over public safety have led to efforts to prohibit beverages containing THC.
• THC Content Restrictions – Some legislators are pushing to cap the THC levels in hemp-derived products, which would limit the potency and availability of these items.

These regulations aim to create clearer distinctions between medical cannabis and unregulated hemp products while addressing safety concerns.

Georgia does not currently have a recreational cannabis market, and there are no immediate plans for legalization. However, the medical cannabis industry is expected to grow, driven by expanded access and legislative reforms. The impact of these changes will depend on the final decisions made by state lawmakers in the coming months.

Georgia's cannabis industry remains at a crossroads, with potential for significant growth in the medical sector alongside tighter regulations on hemp-derived alternatives. The coming legislative sessions will determine the direction of the market and the opportunities available for patients and businesses alike.